Medication info

Mytorin Tablets 10/10 Milligrams

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
IQUR Co., Ltd.
Appearance
White to pale yellow, bilaterally convex rectangular tablets
Packaging
For domestic use - 30 tablets/PTP [(10 tablets/PTPX3)]
Approval status
Expired

MFDS item code 202002326 · Approved 2020.04.02

This product's status changed to Expired on 2025.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available or effective. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and monitor these patients closely when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
IQUR Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used as an adjunct to dietary therapy in patients with primary hypercholesterolemia and mixed hyperlipidemia to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides, and to increase HDL cholesterol. Additionally, it may be administered to patients with homozygous familial hypercholesterolemia when other treatments are insufficient or in combination therapy. This medication should be used alongside an appropriate dietary regimen, taking into account the patient’s risk factors. It is important to check for other secondary causes and to combine treatments if necessary. Regular monitoring of lipid levels is vital to assess the effectiveness of treatment. This medication is used to improve lipid levels in blood for the treatment of hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available or effective. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and monitor these patients closely when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is used to lower cholesterol levels in the blood and helps to reduce the risk of cardiovascular disease. Serious muscle-related adverse reactions, such as myopathy or rhabdomyolysis, may occur when taking this medication, so caution is advised. If symptoms such as muscle pain or weakness appear, consult a physician immediately. Additionally, this medication may affect liver function, so patients with liver disease or abnormally high liver function test results should not take it. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should only take it after confirming the possibility of pregnancy. The risk of myopathy may increase when this medication is taken with certain other drugs; therefore, it is essential to inform the doctor or pharmacist about any medications being taken. Elderly patients and those with chronic kidney disease require closer monitoring when taking this medication. During treatment, it is recommended to regularly check blood tests to monitor liver function and muscle condition. It is advisable to avoid certain foods or drinks, such as grapefruit juice, while taking this medication, and to seek immediate medical help in case of overdose. Lastly, if any new symptoms or adverse reactions arise during treatment with this medication, inform medical personnel immediately and seek consultation.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 101 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • lower back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • drug-induced liver damage
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle spasms
  • specific cranial nerve dysfunction
  • dysgeusia
  • disorders of eye movement
  • facial weakness
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • insomnia
  • nightmares
  • cognitive impairment
  • severe muscle weakness
  • ocular myasthenia
  • interstitial lung disease
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • hepatitis
  • cholecystatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • flat wart-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferase levels
  • elevated ALP
  • elevated ɤ-GT
  • increased bilirubin level
  • thyroid dysfunction
  • increased HbA1c
  • elevated fasting blood sugar levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White to pale yellow, bilaterally convex rectangular tablets

Package unit

For domestic use - 30 tablets/PTP [(10 tablets/PTPX3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.